Myopia Control Spectacle Lens Cessation Study
Public ClinicalTrials.gov record NCT05893979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Myopia Control Spectacle Lens Use Cessation Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.
Study identification
- NCT ID
- NCT05893979
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years to 16 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2023
- Primary completion
- Dec 30, 2026
- Completion
- Jul 30, 2027
- Last update posted
- May 4, 2026
2023 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Golden Optometric Group | Whittier | California | 90606 | — |
| Omega Vision Center PA | Longwood | Florida | 32779 | — |
| Kannarr Eye Care | Pittsburg | Kansas | 66762 | — |
| Advanced Eyecare PC | Raytown | Missouri | 64133 | — |
| Sacco Eye Group | Vestal | New York | 13850 | — |
| Total Eye Care | Memphis | Tennessee | 38119 | — |
| Vision Optique | Houston | Texas | 77205 | — |
| William J Bogus, OD, FAAO | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05893979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05893979 live on ClinicalTrials.gov.